ANDREA STEPHENS: Open Payments
NPI 1588854632 · COLUMBUS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$432 in 26 payments from 11 companies in 2025. Trend: 2023 $338 · 2024 $415 · 2025 $432
Food & beverage: $432
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $70 |
| Amgen Inc. | 4 | $66 |
| Novo Nordisk Inc | 3 | $58 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $47 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $32 |
| Alkermes, Inc. | 2 | $31 |
| Exact Sciences Corporation | 2 | $30 |
| Esperion Therapeutics, Inc. | 1 | $15 |
Products named: OTEZLA, UBRELVY, Kerendia, TRINTELLIX, Ozempic, XIFAXAN, LYBALVI, Cologuard Collection Kit.
Industry payments across IN — which companies pay providers there.
